Veronica Miller

Veronica Miller, PhD, serves as an Adjunct Professor at UC Berkeley School of Public Health and Director of the Washington, D.C.-based Forum for Collaborative Research, leveraging over 145 peer-reviewed publications to advance regulatory science and accelerate drug development for unmet medical needs through public-private partnerships spanning industry, regulatory agencies, and global health communities.

Her academic foundation includes a PhD in Immunology and BSc in Microbiology from the University of Manitoba, complemented by postdoctoral training in Virology at UCLA and Cell Biology at the University of New Mexico.

Dr. Miller's research pioneers regulatory science frameworks for HIV, viral hepatitis (HBV/HCV/CMV), and complex liver diseases, integrating multidisciplinary translational approaches across public health, medicine, data science, and regulatory policy to bridge biomedical innovation with global therapeutic access. Her disease-focused work addresses steatotic/cholestatic liver conditions and ocular diseases through collaborative models emphasizing patient-centered endpoints.

Analysis of her 15 most recent publications reveals dominant themes in standardizing clinical trial endpoints for liver diseases, optimizing regulatory pathways for HIV prevention, and developing consensus definitions for rare disease indications—demonstrating consistent emphasis on data-driven regulatory decision-making and cross-sector collaboration.

Her scientific recognition includes:

• Distinguished Advocacy Service Award from the American Association of Liver Diseases (AASLD) (2024)

As an educator, Dr. Miller mentors future scientists through Berkeley courses including PH 236 (FDA Drug Development Policy) and PHW236A (Regulatory Science), while directing the Forum's Data and Analysis Center to transform clinical trial data into actionable insights for tissue imaging, biomarkers, and histopathology. Her leadership cultivates partnerships that address global health inequities in drug access.

The Forum for Collaborative Research operates as a dynamic hub where multidisciplinary teams from public health, computer science, and regulatory affairs co-develop solutions for high-prevalence and rare diseases, exemplifying Dr. Miller's commitment to turning scientific discovery into real-world health impact.